Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2014 2
2015 1
2017 1
2018 2
2019 2
2020 1
2022 1
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Natural Autoantibodies in Chronic Pulmonary Diseases.
Fukushima K, Tsujino K, Futami S, Kida H. Fukushima K, et al. Among authors: futami s. Int J Mol Sci. 2020 Feb 8;21(3):1138. doi: 10.3390/ijms21031138. Int J Mol Sci. 2020. PMID: 32046322 Free PMC article. Review.
Galectin-10 in serum extracellular vesicles reflects asthma pathophysiology.
Yoshimura H, Takeda Y, Shirai Y, Yamamoto M, Nakatsubo D, Amiya S, Enomoto T, Hara R, Adachi Y, Edahiro R, Yaga M, Masuhiro K, Koba T, Itoh-Takahashi M, Nakayama M, Takata S, Hosono Y, Obata S, Nishide M, Hata A, Yanagawa M, Namba S, Iwata M, Hamano M, Hirata H, Koyama S, Iwahori K, Nagatomo I, Suga Y, Miyake K, Shiroyama T, Fukushima K, Futami S, Naito Y, Kawasaki T, Mizuguchi K, Kawashima Y, Yamanishi Y, Adachi J, Nogami-Itoh M, Ueki S, Kumanogoh A. Yoshimura H, et al. Among authors: futami s. J Allergy Clin Immunol. 2024 May;153(5):1268-1281. doi: 10.1016/j.jaci.2023.12.030. Epub 2024 Mar 29. J Allergy Clin Immunol. 2024. PMID: 38551536 Free article.
Identification of CD14 and lipopolysaccharide-binding protein as novel biomarkers for sarcoidosis using proteomics of serum extracellular vesicles.
Futami Y, Takeda Y, Koba T, Narumi R, Nojima Y, Ito M, Nakayama M, Ishida M, Yoshimura H, Naito Y, Fukushima K, Takimoto T, Edahiro R, Matsuki T, Nojima S, Hirata H, Koyama S, Iwahori K, Nagatomo I, Shirai Y, Suga Y, Satoh S, Futami S, Miyake K, Shiroyama T, Inoue Y, Adachi J, Tomonaga T, Ueda K, Kumanogoh A. Futami Y, et al. Among authors: futami s. Int Immunol. 2022 Jun 4;34(6):327-340. doi: 10.1093/intimm/dxac009. Int Immunol. 2022. PMID: 35294531 Free PMC article.
Cancer-associated SNRPD3 mutation confers resistance to hypoxia, which is attenuated by DRP1 inhibition.
Satoh S, Miyake K, Adachi Y, Masuhiro K, Futami S, Naito Y, Shiroyama T, Koyama S, Yamaguchi Y, Konaka H, Takamatsu H, Okuzaki D, Nagatomo I, Takeda Y, Kumanogoh A. Satoh S, et al. Among authors: futami s. Biochem Biophys Res Commun. 2024 Feb 12;696:149511. doi: 10.1016/j.bbrc.2024.149511. Epub 2024 Jan 10. Biochem Biophys Res Commun. 2024. PMID: 38241813
Monitoring antibody binding to T cells in a pembrolizumab-treated patient with lung adenocarcinoma on hemodialysis.
Osa A, Uenami T, Naito Y, Hirata H, Koyama S, Takimoto T, Shiroyama T, Futami S, Nakatsubo S, Sawa N, Yano Y, Nagatomo I, Takeda Y, Mori M, Kida H, Kumanogoh A. Osa A, et al. Among authors: futami s. Thorac Cancer. 2019 Nov;10(11):2183-2187. doi: 10.1111/1759-7714.13197. Epub 2019 Sep 14. Thorac Cancer. 2019. PMID: 31520515 Free PMC article.
Phase II study of S-1 plus bevacizumab combination therapy for patients previously treated for non-squamous non-small cell lung cancer.
Nishijima-Futami Y, Minami S, Futami S, Koba T, Higashiguchi M, Tamiya M, Suzuki H, Hirashima T, Komuta K, Kijima T. Nishijima-Futami Y, et al. Among authors: futami s. Cancer Chemother Pharmacol. 2017 Jun;79(6):1215-1220. doi: 10.1007/s00280-017-3321-x. Epub 2017 Apr 28. Cancer Chemother Pharmacol. 2017. PMID: 28455584 Clinical Trial.
Phase II trial of induction chemotherapy of pemetrexed plus split-dose cisplatin followed by pemetrexed maintenance for untreated non-squamous non-small-cell lung cancer.
Koba T, Minami S, Nishijima-Futami Y, Masuhiro K, Kimura H, Futami S, Yaga M, Mori M, Kagawa H, Uenami T, Kohmo S, Otsuka T, Yamamoto S, Komuta K, Kijima T. Koba T, et al. Among authors: futami s. Cancer Chemother Pharmacol. 2018 Jul;82(1):111-117. doi: 10.1007/s00280-018-3598-4. Epub 2018 May 4. Cancer Chemother Pharmacol. 2018. PMID: 29728800 Clinical Trial.
16 results